Topics Covered

We invite you to learn more about:

• AML treatment news released at ASH 2018
• How these novel agents will be used in real-world clinics
• Genetic profiling and the role genetic markers play in AML disease course and treatment decisions
• Important updates on AML clinical trial data
• Where research is headed next

Speakers

Beth Kart Probert
Patient Advocate and Host

Naval G. Daver, MD 
Assistant Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center

Leah Szumita, MS, RN
Manager, Clinical Trial Support Center
The Leukemia & Lymphoma Society (LLS)

Steve Buechler
AML Patient

Program Support

Support for this program provided by The Leukemia & Lymphoma Society, Patient Empowerment Network, and Patient Power.

< Back to Webcasts